Search

everythinglearnresearchcommunity

for

Search:↓

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

A new method accurately measures long-term steroid levels in human hair.

5α-reductases increase epitestosterone's effect on androgen receptors.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

A rare ovarian tumor caused high male hormone levels, but surgery fixed it.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

New compounds may help treat prostate issues without affecting androgen receptors.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Mitotane changes steroid breakdown, affecting cortisol availability.

Testosterone's muscle-building effects do not require its conversion to DHT.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.